{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:28:40Z","timestamp":1792726120770,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T00:00:00Z","timestamp":1574035200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1KL2TR002554"],"award-info":[{"award-number":["1KL2TR002554"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K12HD043446"],"award-info":[{"award-number":["K12HD043446"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s10549-019-05500-9","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T13:01:43Z","timestamp":1574082103000},"page":"661-670","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?"],"prefix":"10.1007","volume":"179","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6829-6747","authenticated-orcid":false,"given":"Laura H.","family":"Rosenberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A.","family":"Greenup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwadamilola M.","family":"Fayanju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Shelley","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Plichta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,18]]},"reference":[{"key":"5500_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569\u2013575","journal-title":"JAMA"},{"key":"5500_CR2","unstructured":"National Comprehensive Cancer Network (2018) NCCN, Invasive Cancer, Surgical Axillary Staging. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. Accessed 4 Jan 2019"},{"key":"5500_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/annonc\/mdi060","volume":"16","author":"A Luini","year":"2005","unstructured":"Luini A, Gatti G, Ballardini B et al (2005) Development of axillary surgery in breast cancer. Ann Oncol 16:259\u2013262","journal-title":"Ann Oncol"},{"key":"5500_CR4","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/0959-8049(92)90534-9","volume":"28A","author":"CK Axelsson","year":"1992","unstructured":"Axelsson CK, Mouridsen HT, Zedeler K (1992) Axillary dissection of level I and II lymph nodes is important in breast cancer classification. The Danish Breast Cancer Cooperative Group (DBCG). Eur J Cancer 28A:1415\u20131418","journal-title":"Eur J Cancer"},{"key":"5500_CR5","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1002\/1097-0142(19920515)69:10<2496::AID-CNCR2820691018>3.0.CO;2-T","volume":"69","author":"CI Kiricuta","year":"1992","unstructured":"Kiricuta CI, Tausch J (1992) A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma. Cancer 69:2496\u20132501","journal-title":"Cancer"},{"key":"5500_CR6","first-page":"127","volume":"16","author":"U Veronesi","year":"1990","unstructured":"Veronesi U, Luini A, Galimberti V, Marchini S, Sacchini V, Rilke F (1990) Extent of metastatic axillary involvement in 1446 cases of breast cancer. Eur J Surg Oncol 16:127\u2013133","journal-title":"Eur J Surg Oncol"},{"key":"5500_CR7","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/sim.3841","volume":"29","author":"L Desquilbet","year":"2010","unstructured":"Desquilbet L, Mariotti F (2010) Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 29:1037\u20131057","journal-title":"Stat Med"},{"key":"5500_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-19425-7","volume-title":"Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis","author":"FE Harrell","year":"2015","unstructured":"Harrell FE (2015) Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis. Springer International Publishing, New York"},{"key":"5500_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-1-4612-1694-0_15","volume-title":"Information theory and an extension of the maximum likelihood principle. Selected Papers of Hirotogu Akaike","author":"H Akaike","year":"1998","unstructured":"Akaike H (1998) Information theory and an extension of the maximum likelihood principle. Selected Papers of Hirotogu Akaike. Springer, New York, NY, pp 199\u2013213"},{"key":"5500_CR10","unstructured":"Gradishar WJ, Anderson BO, Aft R, et al (2018) National Comprehensive Cancer Network. NCCN, Invasive Cancer, Version 1.2018. In Kumar R, Shead DA (eds)"},{"key":"5500_CR11","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","volume":"34","author":"AS Caudle","year":"2016","unstructured":"Caudle AS, Yang WT, Krishnamurthy S et al (2016) Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of target axillary dissection. J Clin Oncol 34:1072\u20131078","journal-title":"J Clin Oncol"},{"key":"5500_CR12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","volume":"14","author":"T Kuehn","year":"2013","unstructured":"Kuehn T, Bauerfeind I, Fehm T et al (2013) Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. Lancet Oncol. 14:609\u2013618","journal-title":"Lancet Oncol."},{"key":"5500_CR13","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1001\/jama.2013.278932","volume":"310","author":"JC Boughey","year":"2013","unstructured":"Boughey JC, Suman VJ, Mittendorf EA et al (2013) Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (alliance) clinical trial. JAMA 310:1455\u20131461","journal-title":"JAMA"},{"key":"5500_CR14","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1002\/1097-0142(19800615)45:12<2917::AID-CNCR2820451203>3.0.CO;2-M","volume":"45","author":"T Nemoto","year":"1980","unstructured":"Nemoto T, Vana J, Bedwani RN et al (1980) Management and survival of female breast cancer: results of a National Survey by the American College of Surgeons. Cancer 45:2917\u20132924","journal-title":"Cancer"},{"key":"5500_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H","volume":"63","author":"CL Carter","year":"1989","unstructured":"Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181\u2013187","journal-title":"Cancer"},{"key":"5500_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.soc.2017.07.010","volume":"27","author":"JK Plichta","year":"2018","unstructured":"Plichta JK, Campbell BM, Mittendorf EA et al (2018) Anatomy and breast cancer staging: is it still relevant? Surg Oncol Clin N Am 27:51\u201367","journal-title":"Surg Oncol Clin N Am"},{"key":"5500_CR17","unstructured":"AJCC Cancer Staging Manual (ed 8th) (2016) Springer International Publishing, New York"},{"key":"5500_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1245\/s10434-013-3245-6","volume":"21","author":"S Chen","year":"2014","unstructured":"Chen S, Liu Y, Huang L et al (2014) Lymph node counts and ratio in axillary dissections following neoadjuvant chemotherapy for breast cancer: a better alternative to traditional pN staging. Ann Surg Oncol 21:42\u201350","journal-title":"Ann Surg Oncol"},{"key":"5500_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJMoa1415340","volume":"373","author":"TJ Whelan","year":"2015","unstructured":"Whelan TJ, Olivotto IA, Parulekar WR et al (2015) Regional nodal irradiation in early-stage breast cancer. N Engl J Med 373:307\u2013316","journal-title":"N Engl J Med"},{"key":"5500_CR20","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1415369","volume":"373","author":"PM Poortmans","year":"2015","unstructured":"Poortmans PM, Collette S, Kirkove C et al (2015) Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med 373:317\u2013327","journal-title":"N Engl J Med"},{"key":"5500_CR21","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.radonc.2007.02.001","volume":"82","author":"M Overgaard","year":"2007","unstructured":"Overgaard M, Nielsen HM, Overgaard J (2007) Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol 82:247\u2013253","journal-title":"Radiother Oncol"},{"key":"5500_CR22","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(14)60488-8","volume":"383","author":"P McGale","year":"2014","unstructured":"EBCTCG (Early Breast Cancer Trialists\u2019 Collaborative Group), McGale P, Taylor C et al (2014) Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet 383:2127\u20132135","journal-title":"Lancet"},{"key":"5500_CR23","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1200\/JCO.2005.06.178","volume":"23","author":"IA Olivotto","year":"2005","unstructured":"Olivotto IA, Bajdik CD, Ravdin PM et al (2005) Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 23:2716\u20132725","journal-title":"J Clin Oncol"},{"key":"5500_CR24","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1186\/bcr2464","volume":"12","author":"GC Wishart","year":"2010","unstructured":"Wishart GC, Azzato EM, Greenberg DC et al (2010) PREDICT: a New UK prognostic model that predicts survival following surgery for invasive breast cancer. Breast Cancer Res 12:R1","journal-title":"Breast Cancer Res"},{"issue":"10","key":"5500_CR25","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.ejso.2006.06.005","volume":"32","author":"B Kuru","year":"2006","unstructured":"Kuru B (2006) Prognostic significance of total number of nodes removed, negative nodes removed, and ratio of positive nodes to removed nodes in node positive breast carcinoma. Eur J Surg Oncol 32(10):1082\u20131088","journal-title":"Eur J Surg Oncol"},{"key":"5500_CR26","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.2147\/OTT.S152936","volume":"11","author":"X Wang","year":"2018","unstructured":"Wang X, Ji C, Chi H et al (2018) How many ELNs are optimal for breast cancer patients with more than three PLNs who underwent MRM? A large population-based study. Onco Targets Ther 11:1005\u20131011","journal-title":"Onco Targets Ther"},{"issue":"Suppl 1","key":"5500_CR27","doi-asserted-by":"publisher","first-page":"S46","DOI":"10.1016\/S0022-510X(09)71300-0","volume":"287","author":"MP Sormani","year":"2009","unstructured":"Sormani MP (2009) The Will Rogers phenomenon: the effect of different diagnostic criteria. J Neurol Sci 287(Suppl 1):S46","journal-title":"J Neurol Sci"},{"key":"5500_CR28","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.jamcollsurg.2012.12.016","volume":"216","author":"K Mallin","year":"2013","unstructured":"Mallin K, Palis BE, Watroba N et al (2013) Completeness of American Cancer Registry Treatment Data: implications for Quality of Care Research. J Am Coll Surg 216:428\u2013437","journal-title":"J Am Coll Surg"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05500-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-019-05500-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-019-05500-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T03:33:20Z","timestamp":1722051200000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-019-05500-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,18]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["5500"],"URL":"https:\/\/doi.org\/10.1007\/s10549-019-05500-9","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,18]]},"assertion":[{"value":"23 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Due to use of national de-identified data (National Cancer Data Base, NCDB), our institutional review board granted the study exempt status and no individual informed consent was needed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}